The store will not work correctly when cookies are disabled.
[18F]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide
ID: ALA3088243
Chembl Id: CHEMBL3088243
Cas Number: 1482497-85-7
PubChem CID: 73443026
Max Phase: Preclinical
Molecular Formula: C16H14FN5OS
Molecular Weight: 343.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CNc1cc(-c2csc(N(C)C(=O)c3ccc([18F])cc3)n2)ncn1
Standard InChI: InChI=1S/C16H14FN5OS/c1-18-14-7-12(19-9-20-14)13-8-24-16(21-13)22(2)15(23)10-3-5-11(17)6-4-10/h3-9H,1-2H3,(H,18,19,20)/i17-1
Standard InChI Key: UTPGRZGMQVAYAA-SJPDSGJFSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.39 | Molecular Weight (Monoisotopic): 343.0903 | AlogP: 3.06 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.01 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.44 | CX LogP: 2.98 | CX LogD: 2.98 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -2.07 |
References
1. Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW.. (2013) Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1)., 56 (22): [PMID:24147864] [10.1021/jm4012017] |